AKESOgen competitorsClear all

AKESOgen's top competitors include AveXis, Idera Pharmaceuticals, Hospira and Atopix.
AKESOgen
AKESOgen
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
AveXis
AveXis
AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
Idera Pharmaceuticals
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Hospira
Hospira
Is the worlds leading provider of injectable drugs and infusion technologies.
Atopix
Atopix
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK
Founding Date
Founding Date
2010
Founding Date
2010
Founding Date
1989
Founding Date
N/A
Founding Date
2012
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Norcross, US HQ
Locations
Bannockburn, US HQ
Locations
Cambridge, US HQ
Exton, US
Locations
Lake Forest, US HQ
Locations
Milton, GB HQ
Employees
Employees
418% increase
Employees
N/A
Employees
3642% decrease
Employees
N/A
Employees
N/A
Twitter followers
Twitter followers
58
Twitter followers
1.8 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
368384
Alexa Website Rank
563109
Alexa Website Rank
427003
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.7
Employee Rating
3.4
Employee Rating
4.3
Employee Rating
3.2
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
£453.4k (FY, 2017)
Net income
Net income
N/A
Net income
($218.1m) (FY, 2017)
Net income
($56.5m) (FY, 2019)
Net income
N/A
Net income
£592.1k (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 1.3m (over 6 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 5.1m (almost 5 years ago)
Total funding raised
Total funding raised
$ 1.5m
Total funding raised
$ 75m
Total funding raised
$ 13.8m
Total funding raised
N/A
Total funding raised
$ 5.1m
For sources of this data, please see the company profile

View company profiles

AveXis
HQ
Bannockburn, US

AveXis is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.

View company
Idera Pharmaceuticals
HQ
Cambridge, US
Employees
36↓ 42% decrease

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

View company
Hospira
HQ
Lake Forest, US

Is the worlds leading provider of injectable drugs and infusion technologies.

View company
Atopix
HQ
Milton, GB

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK

View company